Related Experiment Video
Updated: Apr 7, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
DNA-dependent targeting of cell nuclei by a lupus autoantibody
Richard H Weisbart1, Grace Chan1, Gwen Jordaan1
1Department of Research, Veterans Affairs Greater Los Angeles Healthcare System, Sepulveda, CA 91343.
Abstract:
A nuclear-penetrating lupus anti-DNA autoantibody, 3E10, has been found to inhibit DNA repair and selectively kill certain cancer cells that are highly vulnerable to DNA damage. In addition, a 3E10 single chain variable fragment (scFv) has been developed for use as a delivery vehicle to carry therapeutic cargo proteins into cell nuclei. A greater understanding of the mechanism by which 3E10 penetrates cell nuclei is needed to help determine the scope of its potential therapeutic applications. Here we show that the presence of extracellular DNA significantly enhances the nuclear uptake of 3E10 scFv. In addition, we find that 3E10 scFv preferentially localizes into tumor cell nuclei in vivo, likely due to increased DNA in the local environment released from ischemic and necrotic regions of tumor. These data provide insight into the mechanism of nuclear penetration by 3E10 and demonstrate the potential for use of 3E10 in therapeutic approaches to diseases ranging from malignancy to ischemic conditions such as stroke.
Insights
A lupus autoantibody (3E10) and its fragment (scFv) enter cell nuclei, enhanced by extracellular DNA. This mechanism aids targeted cancer therapy and treatment for ischemic conditions.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- The lupus anti-DNA autoantibody 3E10 penetrates cell nuclei, inhibits DNA repair, and selectively kills cancer cells.
- A 3E10 single chain variable fragment (scFv) is engineered as a nuclear delivery vehicle for therapeutic proteins.
Purpose of the Study:
- To elucidate the mechanism of nuclear penetration by 3E10 scFv.
- To assess the potential therapeutic applications of 3E10 scFv.
Main Methods:
- Investigated the effect of extracellular DNA on 3E10 scFv nuclear uptake in vitro.
- Evaluated the in vivo biodistribution and nuclear localization of 3E10 scFv in tumor models.
Main Results:
- Extracellular DNA significantly enhances the nuclear uptake of 3E10 scFv.
- 3E10 scFv demonstrates preferential nuclear localization in tumor cells in vivo.
- Tumor-specific nuclear accumulation is linked to elevated DNA in the tumor microenvironment from ischemic and necrotic regions.
Conclusions:
- The presence of extracellular DNA is a key factor in 3E10 scFv nuclear penetration.
- 3E10 scFv exhibits tumor-targeting potential, suggesting applications in cancer therapy.
- The findings support the therapeutic use of 3E10 in malignancies and ischemic diseases like stroke.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Regulation of Nuclear Protein Sorting

